SamuelJacobSlomowitzMD

Breast Cancer, Hematologic Oncology, Thoracic Cancer

UCLA Asssitant Professor of Medicine

Dr. Slomowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Triple boarded in Hematology, Medical Oncology, and Internal Medicine. Specializing in personalized medicine and care for everything from blood disorders to Breast Cancer

University of Utah HealthFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Utah HealthResidency, Internal Medicine, 2008 - 2011
St. George's University School of MedicineClass of 2008

PubMed

18 citations
Management of Extramedullary Leukemia as a Presentation of Acute Myeloid Leukemia
Samuel J. Slomowitz, Paul J. Shami> ;Journal of the National Comprehensive Cancer Network. 2012 Sep 1
Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.
Semiletova, N. V., Shen, X. D., Slomowitz, S. J., Baibakov, B., Feldman, D. M., Busuttil, R. W., Kupiec-Weglinski, J. W., Ghobrial, R. M.> ;Transplant Proc. 2005 Apr 06
11 citations
Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance.
Natalya Semiltova, Xiu Da Shen, Michael C. Fishbein, F. Gao, Samuel J. Slomowitz, Qingsheng Jiao, Kaushik Mukherjee, Ronald W. Busuttil, Jerzy W. Kupiec-Weglinski, Raf...> ;Transplantation. 2003 Feb 27
Regulatory T cells induced by allochimeric major histocompatability class I therapy inhibit allograft apoptosis.
Semiletova, N., Shen, X. D., Gao, F., Slomowitz, S. J., Jiao, Q., Busuttil, R. W., Kupiec-Weglinski, J. W., Ghobrial, R. M.> ;Transplant Proc. 2002 Aug
Join now to see all